MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and PPARγ

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIGURE 6.
FIGURE 6.

The effect of PGC1α and PPARγ on the expression of miR-130a. (A) The expression level of miR-130a was not affected in stable PGC1α-expressing HepG2 or HuH7 cell lines. (B) (Upper panel) Reduction of miR-130a was observed in PPARγ-expressing HepG2 cell lines using stem–loop qPCR. U6 snRNA was used as an internal control for normalization. Rosiglitazone, but not GW9662, further reduced the expression of miR-130a. (Lower panel) Increased amounts of PPARγ protein in stable PPARγ-expressing HepG2 cell lines were detected by Western blot. (C) This cartoon summarizes the relationships among PPARγ, PGC1α, miR-130a, and HBV. A feed-forward amplification loop among HBV, PGC1α, and PPARγ can be mediated through a miR-130a intermediate. The symbol ++ represents an enhanced stimulatory effect from the combination of PGC1α and PPARγ.

This Article

  1. RNA 21: 385-400